Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy

Rituximab, a chimeric monoclonal antibody directed against CD20, has become a part of the standard therapy for patients with non-Hodgkin's lymphoma either in combination with other drugs or as a single agent. The CD20 antigen is expressed on 95% of B-cell lymphoma cells and normal B-cells but,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yuna, Kyung, Sun Young, Choi, Soo Jin, Bang, Soo-Mee, Jeong, Seong Hwan, Shin, Dong Bok, Lee, Jae Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2006
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890722/
https://www.ncbi.nlm.nih.gov/pubmed/17017668
http://dx.doi.org/10.3904/kjim.2006.21.3.183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890722/
https://www.ncbi.nlm.nih.gov/pubmed/17017668
http://dx.doi.org/10.3904/kjim.2006.21.3.183

Ejemplares similares